ERAS
Erasca, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
Erasca, Inc.
14.20
+1.47%
vs ±13.2% implied · ×0.11
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences ManagementFrazier Life Sciences | $457.5M | 8.64% | +1.22% | |
| 2 | T. Rowe Price Investment ManagementT. Rowe Price | $388.1M | 7.33% | −0.35% | |
| 3 | BlackRockBlackRockindex-like | $387.5M | 7.32% | +4.98% | |
| 4 | RTW InvestmentsRTW | $328.8M | 6.21% | +11.08% | |
| 5 | VR AdviserVR Adviser | $327.8M | 6.19% | +9.21% | |
| 6 | State StreetState Streetindex-like | $223.2M | 4.21% | +31.02% | |
| 7 | Logos Global ManagementLogos Global | $222.6M | 4.20% | +8.97% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $208.9M | 3.94% | +1.36% | |
| 9 | SirenSiren | $208.8M | 3.94% | +1.37% | |
| 10 | Paradigm Biocapital AdvisorsParadigm Biocapital | $175.0M | 3.30% | −8.11% | |
| 11 | Arch VentureArch Venture | $129.9M | 2.45% | 0.00% | |
| 12 | Geode Capital ManagementGeodeindex-like | $119.1M | 2.25% | +8.43% | |
| 13 | T. Rowe Price AssociatesT. Rowe Price | $114.9M | 2.17% | +245.53% | |
| 14 | Cormorant Asset ManagementCormorant | $109.9M | 2.08% | +3.45% | |
| 15 | Caption ManagementCaption | $100.9M | 1.90% | +798.81% | |
| 16 | Affinity Asset AdvisorsAffinity Asset | $96.2M | 1.82% | −1.87% | |
| 17 | Vivo CapitalVivo Capital | $75.6M | 1.43% | −66.03% | |
| 18 | AlliancebernsteinAlliancebernstein | $75.5M | 1.42% | +55.72% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $70.0M | 1.32% | −21.60% | |
| 20 | Bank of AmericaBank of America | $55.9M | 1.05% | −0.23% | |
| 21 | FMRFMR | $52.8M | 1.00% | +93.51% | |
| 22 | AH Capital ManagementAH Capital Management | $52.4M | 0.99% | 0.00% | |
| 23 | Woodline PartnersWoodline Partners | $51.9M | 0.98% | +0.01% | |
| 24 | Jennison AssociatesJennison | $51.1M | 0.96% | new | |
| 25 | Soleus Capital ManagementSoleus | $49.5M | 0.93% | new |
257 managers report $5.3B of Erasca on form 13F for the quarter ended Jun 30 '26. 28 of them hold 80% of it; Frazier Life Sciences is largest at 8.64%.
No implied move.
No implied move.
Expected move
No implied move.